NEUP NASDAQ
Neuphoria Therapeutics Inc.
1W: -4.9%
1M: -7.5%
3M: +0.9%
YTD: -9.2%
1Y: -75.0%
3Y: -70.6%
$3.47
-0.04 (-1.14%)
Weekly Expected Move ±2.0%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
-91.9% YoY
$-19M
Net Income
-1405.2% YoY
$-12,354M
Free Cash Flow
-16096.1% YoY
85.9%
Gross Margin
-14.0%
Op. Margin
-417.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-0.2%
ROA-0.1%
ROIC-0.2%
Valuation
P/E-0.5
P/B0.8
EV/EBITDA1578.7
Leverage
Debt/Equity0.00
Current Ratio27.85
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z-8.50
Beneish M0.00